FDA Recalls More Bottles of Blood Pressure Medication Due to Quality Issue
· Telemundo McAllen (KTLM)
A popular blood pressure medication is being recalled for the second time this year by the Food and Drug Administration (FDA) due to a quality issue. The recall, involving 25 mg chlorthalidone tablets, was initially issued earlier this year because the pills do not dissolve properly, affecting over 11,400 bottles at that time. The current recall now includes 13,567 bottles, according to a September FDA compliance report. The bottles belong to lot number RISA24002, with an expiration date of April 2027. According to the FDA, the pills are available by prescription only and were distributed nationwide. The recall has been classified as 'Class II,' indicating a moderate risk level. The FDA states that exposure to any product under a 'Class II' recall means that the likelihood of serious health consequences is remote. Mayo Clinic reports that chlorthalidone 'is used alone or with other medications to treat high blood pressure (hypertension).' It can also be used to treat fluid retention. This is not the only recent recall of a blood pressure medication. In October 2025, over half a million bottles of prazosin hydrochloride were recalled due to concerns that they contained unsafe levels of a carcinogenic chemical, prompting the manufacturer to advise patients taking the pills to contact their doctor or pharmacy if they have the product.
AI summary · Source: Telemundo McAllen (KTLM) →
